AVITA Medical study shows RECELL helps acne scars

Company News

by Rachael Jones

Regenerative medicine company AVITA Medical (ASX:AVH) has had a study into treating acne scars published in Aesthetic Plastic Surgery by the Department of Plastic Surgery at Peking Union Medical College Hospital exploring the use of the RECELL.

RECELL was used in combination with dermabrasion to treat facial acne scars.

They found that acne scars treated using dermabrasion healed more quickly on average with RECELL (5.27 ± 1.086 days) than without RECELL (average healing time of 12.30 ± 1.725 days).

In addition, there were no postoperative complications, such as pigmentation and scar hyperplasia, and higher patient satisfaction rates for those patients treated with RECELL.

Shares in AVITA Medical (ASX:AVH) are trading 4.2 per cent lower at 57 cents.

Rachael Jones

Finance News Network
Rachael comes to FNN after working for Fairfax Media covering international breaking news, including the global economy and politics. She joined FNN in February 2018. She has reported on Australia’s finance news for various organisations since 2000 and has also interviewed a number of key business players, including Bill Gates. Rachael has also worked across a number of countries, including the UK and the US.